Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

'Difficult to treat' rheumatoid arthritis: current position and considerations for next steps
Yvonne Tan, Maya H Buch
RMD Open (2022) Vol. 8, Iss. 2, pp. e002387-e002387
Open Access | Times Cited: 45

Showing 26-50 of 45 citing articles:

The potential role of fatigue in difficult-to-treat rheumatoid arthritis
Leticia León, D. Freites, Alfredo Madrid-García, et al.
BMC Rheumatology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 1
A new pharmacokinetic model of urinary methotrexate to assess adherence in rheumatoid arthritis
M. Geoffroy, Claire Gozalo, Céline Konecki, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115620-115620
Open Access | Times Cited: 4
ReLiFiRa (Real Life Filgotinib in Rheumatoid Arthritis): Retrospective Study of Efficacy and Safety in Common Clinical Practice
Maurizio Benucci, Marco Bardelli, Massimiliano Cazzato, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1303-1303
Open Access | Times Cited: 3
UPLC-Q-TOF-MS/MS-based urine metabolomics studies on the toxicity and detoxication of Tripterygium wilfordii Hook. f. after roasting
Shu Chen, Li Liu, Hong‐Xia Jiang, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 234, pp. 115573-115573
Closed Access | Times Cited: 2
Long-term use of glucocorticoids in patients with active rheumatoid arthritis: therapeutic "freeze frame"
А. В. Гордеев, E. V. Matyanova, Е. А. Галушко
Terapevticheskii arkhiv (2023) Vol. 95, Iss. 5, pp. 380-385
Open Access | Times Cited: 2
Artrite reumatoide - uma revisão abrangente sobre as causas e fatores de risco, diagnóstico, tratamento, complicações e prognóstico
Diego Soares Loureiro, Ana Carolina de Lima Teixeira, Deborah Ferreira Duguet Arruda, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 1, pp. 3708-3717
Open Access
Glucagon-like peptide-1 receptor agonists: Prospects for use in rheumatology
Е. Л. Насонов, Т. С. Паневин, Е. А. Трошина
Rheumatology Science and Practice (2024) Vol. 62, Iss. 2, pp. 135-144
Open Access
Exploring the therapeutic opportunities of potassium channels for the treatment of rheumatoid arthritis
Nikhil Eknath More, Rahul Mandlik, Sandip Zine, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Non-TNF biologics and their biosimilars in rheumatoid arthritis
Tsz Ching Mok, Chi Chiu Mok
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 7, pp. 599-613
Closed Access
Urinary methotrexate dosage in rheumatoid arthritis, in patients treated for at least 6 months: a potential marker of adherence
N. Théate, M. Geoffroy, Lukshe Kanagaratnam, et al.
RMD Open (2024) Vol. 10, Iss. 2, pp. e004024-e004024
Open Access
[Identification of potential biomarkers and immunoregulatory mechanisms of rheumatoid arthritis based on multichip co-analysis of GEO database].
Lingxi Chen, Tianyu Wu, M Zhang, et al.
PubMed (2024) Vol. 44, Iss. 6, pp. 1098-1108
Closed Access
Artrite reumatóide - uma revisão abrangente sobre etiologia, epidemiologia, fisiopatologia, manifestações clínicas, diagnóstico e tratamento
Vitoria Zaninetti Conti, Bárbara Marangoni, Beatriz Teixeira Pereira, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 4, pp. e71603-e71603
Open Access
Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study
Wen Qi, Antoine Robert, Narcisse Singbo, et al.
Advances in Rheumatology (2024) Vol. 64, Iss. 1
Open Access
The journey of pain management for fibromyalgia patients: A ten year experience from Tunisia
S. Bouden, Hadwa Beji, L. Rouached, et al.
The Egyptian Rheumatologist (2024) Vol. 46, Iss. 4, pp. 194-197
Closed Access
Truth unveiled by time and the marbled definition of D2T-RA: retrospective analysis on the persistence of the difficult-to-treat status among refractory RA patients
Gilberto Cincinelli, Gabriella Maioli, C. Posio, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access
Machine learning-enhanced clinical and ultrasound technology for early detection of difficult-to-treat rheumatoid arthritis
T Wang, Zhen Wang, Yanling Yu, et al.
Research Square (Research Square) (2024)
Open Access
Timely escalation to second-line therapies after failure of methotrexate in patients with early rheumatoid arthritis does not reduce the risk of becoming difficult-to-treat
Bernardo D’Onofrio, Ludovico De Stefano, Emanuele Bozzalla Cassione, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access
Expressions of Peptidoglycan Recognition Protein 1, Neuron Towards Axon Guidance Factor-1 and miR-142-3p and Their Correlations in Patients with Rheumatoid Arthritis
Zhijian Chen, Juanjuan Xu, Jingzhe Sui, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 3457-3464
Open Access | Times Cited: 1
The identification, goals and principles of difficult-to-treat inflammatory arthritis: a consensus statement
Yasser El Miedany, Mohammed Hassan Abu-Zaid, Maha El Gaafary, et al.
Egyptian Rheumatology and Rehabilitation (2023) Vol. 50, Iss. 1
Open Access | Times Cited: 1
Le concept de maladie difficile à traiter (D2T) est-il applicable à la spondyloarthrite axiale ?
Daniel Wendling, Frank Verhoeven, Clément Prati
Revue du Rhumatisme (2023) Vol. 90, Iss. 6, pp. 689-693
Closed Access
Previous Page - Page 2

Scroll to top